Literature DB >> 2001377

Metabolic origin of urinary 3-hydroxy dicarboxylic acids.

K Y Tserng1, S J Jin.   

Abstract

3-Hydroxy dicarboxylic acids with chain lengths ranging from 6 to 14 carbons are excreted in human urine. The urinary excretion of these acids is increased in conditions of increased mobilization of fatty acids or inhibited fatty acid oxidation. Similar urinary profiles of 3-hydroxy dicarboxylic acids were also observed in fasting rats. The metabolic genesis of these urinary 3-hydroxy dicarboxylic acids was investigated in vitro with rat liver postmitochondrial and mitochondrial fractions. 3-Hydroxy monocarboxylic acids ranging from 3-hydroxyhexanoic acid to 3-hydroxyhexadecanoic acid were synthesized. In the rat liver postmitochondrial fraction fortified with NADPH, these 3-hydroxy fatty acids with carbon chains equal to or longer than 10 were oxidized to (omega - 1)- and omega-hydroxy metabolites as well as to the corresponding 3-hydroxy dicarboxylic acids. 3-Hydroxyhexanoic (3OHMC6) and 3-hydroxyoctanoic (3OHMC8) acids were not metabolized. Upon the addition of mitochondria together with ATP, CoA, carnitine, and MgCl2, the 3-hydroxy dicarboxylic acids were converted to 3-hydroxyoctanedioic, trans-2-hexenedioic, suberic, and adipic acids. In the urine of children with elevated 3-hydroxy dicarboxylic acid levels, 3OHMC6, 3OHMC8, 3-hydroxydecanoic, 3,10-dihydroxydecanoic, 3,9-dihydroxydecanoic, and 3,11-dihydroxydodecanoic acids were identified. On the basis of these data, we propose that the urinary 3-hydroxy dicarboxylic acids are derived from the omega-oxidation of 3-hydroxy fatty acids and the subsequent beta-oxidation of longer chain 3-hydroxy dicarboxylic acids. These urinary 3-hydroxy dicarboxylic acids are not derived from the beta-oxidation of unsubstituted dicarboxylic acids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001377     DOI: 10.1021/bi00223a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells.

Authors:  Andréa T Faccio; Francisco J Ruperez; Nagendra S Singh; Santiago Angulo; Marina F M Tavares; Michel Bernier; Coral Barbas; Irving W Wainer
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-09       Impact factor: 3.770

2.  The absolute configurations of hydroxy fatty acids from the royal jelly of honeybees (Apis mellifera).

Authors:  Tetsuya Kodai; Takafumi Nakatani; Naoki Noda
Journal:  Lipids       Date:  2010-11-17       Impact factor: 1.880

3.  Rewired metabolism in drug-resistant leukemia cells: a metabolic switch hallmarked by reduced dependence on exogenous glutamine.

Authors:  Claudia Stäubert; Hasanuzzaman Bhuiyan; Anna Lindahl; Oliver Jay Broom; Yafeng Zhu; Saiful Islam; Sten Linnarsson; Janne Lehtiö; Anders Nordström
Journal:  J Biol Chem       Date:  2015-02-19       Impact factor: 5.157

4.  Analysis of 3-hydroxydodecanedioic acid for studies of fatty acid metabolic disorders: preparation of stable isotope standards.

Authors:  J S Chickos; Barbara A Way; J Wilson; M Shaharuzzaman; J Laird; M Landt
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

5.  Reduction pathway of cis-5 unsaturated fatty acids in intact rat-liver and rat-heart mitochondria: assessment with stable-isotype-labelled substrates.

Authors:  K Y Tserng; S J Jin; L S Chen
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

6.  Stereoselective analysis of 2-hydroxysebacic acid in urine of patients with Zellweger syndrome and of premature infants fed with medium-chain triglycerides.

Authors:  A Muth; A Mosandl; R J A Wanders; M J M Nowaczyk; I Baric; H Böhles; A C Sewell
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Authors:  Jeremiah Bowers; Emma Hughes; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-02       Impact factor: 3.205

8.  ¹H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet.

Authors:  Ze-Yun Li; Li-Li Ding; Jin-Mei Li; Bao-Li Xu; Li Yang; Kai-Shun Bi; Zheng-Tao Wang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  In Vivo Characterization of the Toxicological Properties of DPhP, One of the Main Degradation Products of Aryl Phosphate Esters.

Authors:  Samia Selmi-Ruby; Jesús Marín-Sáez; Aurélie Fildier; Audrey Buleté; Myriam Abdallah; Jessica Garcia; Julie Deverchère; Loïc Spinner; Barbara Giroud; Sébastien Ibanez; Thierry Granjon; Claire Bardel; Alain Puisieux; Béatrice Fervers; Emmanuelle Vulliet; Léa Payen; Arnaud M Vigneron
Journal:  Environ Health Perspect       Date:  2020-12-09       Impact factor: 9.031

10.  Murine deficiency of peroxisomal L-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasis.

Authors:  Pablo Ranea-Robles; Sara Violante; Carmen Argmann; Tetyana Dodatko; Dipankar Bhattacharya; Hongjie Chen; Chunli Yu; Scott L Friedman; Michelle Puchowicz; Sander M Houten
Journal:  Cell Mol Life Sci       Date:  2021-06-10       Impact factor: 9.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.